Aripiprazole: A Case for Side Effect Awareness
Aims: Aripiprazole, an atypical antipsychotic, is commonly prescribed for various psychiatric conditions including schizophrenia and bipolar disorder. It is generally considered to have a more favourable side effect profile compared with other antipsychotics, with a lower risk of metabolic side effe...
Saved in:
Main Author: | Mario Lepore |
---|---|
Format: | Article |
Language: | English |
Published: |
Cambridge University Press
2025-06-01
|
Series: | BJPsych Open |
Online Access: | https://www.cambridge.org/core/product/identifier/S2056472425107448/type/journal_article |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Low-dose aripiprazole for refractory burning mouth syndrome
by: Umezaki Y, et al.
Published: (2016-05-01) -
The Impact of a Manufacturing Process on the Stability of Microcrystalline Long-Acting Injections: A Case Study on Aripiprazole Monohydrate
by: Tomasz Pietrzak, et al.
Published: (2025-06-01) -
Comparative cardiometabolic safety and effectiveness of aripiprazole in people with severe mental illness: A target trial emulation.
by: Alvin Richards-Belle, et al.
Published: (2025-01-01) -
A retrospective study of predictive factors for effective aripiprazole augmentation of antidepressant therapy in treatment-resistant depression
by: Sugawara H, et al.
Published: (2016-05-01) -
A randomized trial of aripiprazole vs blonanserin for the treatment of acute schizophrenia and related disorders
by: Kishi T, et al.
Published: (2016-11-01)